Furthermore, they found that SFN enhances receptor tyrosine kinases stabilization by aberrant ubiquitin-specific protease 8 (USPB) regulation in lung adenocarcinoma, implying that SFN could be an appropriate therapeutic target for lung adenocarcinoma than USP8 [17]. This evidence concerns the gene NTRK1 and lung adenocarcinoma.